Head-to-head · WeighScore
HelloWellness vs Spry
The verdict
HelloWellness takes it — 61.2/100 to 56.8/100.
HelloWellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. HelloWellness (hellowellness.health) is a compounded GLP-1 telehealth platform offering compounded semaglutide starting at $133/month and compounded tirzepatide starting at $166/month, with a 3-month plan…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | HelloWellness | Spry |
|---|---|---|
| WeighScore | 61.2/100 | 56.8/100 |
| Grade | C | C |
| Scorecard rank | #298 | #408 |
| Semaglutide | $133/mo (starting dose, compounded) | $199/mo (starting dose, compounded) |
| Tirzepatide | $166/mo (starting dose, compounded) | $299/mo (starting dose, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #298 · C
Strengths
- $133/mo starting price for compounded semaglutide is among the cheapest in the US compounded market
- $166/mo starting price for compounded tirzepatide is competitive with established platforms
- Every shipment includes syringes, needles, and injection instructions
- Cancel anytime after the 3-month minimum, stated clearly
- Private Facebook community for patient support
Where it loses points
- 3-month minimum plan — you pay for all 3 months even if you stop early
- LegitScript seal is for a related domain (hellowellness.ai), not hellowellness.health — confirm it's the same entity
- Parent company / legal entity not disclosed
- States served not listed publicly
- Pharmacy partners not named
Graded #408 · C
Strengths
- Three named co-founders disclosed (Gabriel Mullins, Sara Yoder, Tyler Bowman) — better-than-average transparency
- Pricing shown on the homepage ($199 semaglutide / $299 tirzepatide / $249–$299 peptides) — no full sign-up wall
- Broader range (2 GLP-1s plus 3 anti-aging peptides) appeals to longevity buyers
- No contracts or commitment required
- LegitScript Certified with a public verification link
Where it loses points
- Displays an "FDA Approved" badge though compounded GLP-1s are not FDA-approved finished drugs — potentially misleading
- Intake reviewed by a nurse practitioner, not an MD
- States served not disclosed publicly
- Pharmacy partner not named, and 503A vs 503B designation not specified
- FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.